BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15832374)

  • 1. Site-directed mutations (Asp405Ile and Glu124Ile) in cytochrome P450scc: effect on adrenodoxin binding.
    Ghisellini P; Paternolli C; Nicolini C
    J Cell Biochem; 2005 Jul; 95(4):720-30. PubMed ID: 15832374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the interaction of bovine cytochrome P450scc (CYP11A1) with adrenodoxin: evaluating site-directed mutations by molecular modeling.
    Usanov SA; Graham SE; Lepesheva GI; Azeva TN; Strushkevich NV; Gilep AA; Estabrook RW; Peterson JA
    Biochemistry; 2002 Jul; 41(26):8310-20. PubMed ID: 12081479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative structural-functional characterization of recombinant and natural adrenodoxin. Interaction with cytochrome P450scc.
    Lepesheva GI; Azeva TN; Strushkevich NV; Adamovich TB; Cherkesova TS; Usanov SA
    Biochemistry (Mosc); 1999 Sep; 64(9):1079-88. PubMed ID: 10521726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction domain of the redox protein adrenodoxin is mandatory for binding of the electron acceptor CYP11A1, but is not required for binding of the electron donor adrenodoxin reductase.
    Heinz A; Hannemann F; Müller JJ; Heinemann U; Bernhardt R
    Biochem Biophys Res Commun; 2005 Dec; 338(1):491-8. PubMed ID: 16137649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of catalytically active human cytochrome p450scc in Escherichia coli and mutagenesis of isoleucine-462.
    Woods ST; Sadleir J; Downs T; Triantopoulos T; Headlam MJ; Tuckey RC
    Arch Biochem Biophys; 1998 May; 353(1):109-15. PubMed ID: 9578606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of positively charged residues lys267, lys270, and arg411 of cytochrome p450scc (CYP11A1) in interaction with adrenodoxin.
    Strushkevich NV; Azeva TN; Lepesheva GI; Usanov SA
    Biochemistry (Mosc); 2005 Jun; 70(6):664-71. PubMed ID: 16038609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative structural and immunochemical characterization of recombinant and natural cytochrome p450scc (CYPXIAI).
    Lepesheva GI; Usanov SA
    Biochemistry (Mosc); 1998 Feb; 63(2):224-34. PubMed ID: 9526119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of In Vivo Activity of the Bovine Cholesterol Hydroxylase/Lyase System Proteins Expressed in Escherichia coli.
    Efimova VS; Isaeva LV; Rubtsov MA; Novikova LA
    Mol Biotechnol; 2019 Apr; 61(4):261-273. PubMed ID: 30729436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of cytochrome P450scc (CYP11A1). Effect of lysine residue substitution on its structural and functional properties.
    Lepesheva GI; Azeva TN; Strushkevich NV; Gilep AA; Usanov SA
    Biochemistry (Mosc); 2000 Dec; 65(12):1409-18. PubMed ID: 11173513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstruction of mitochondrial cytochrome P450-dependent steroid hydroxylases in artificial phospholipid membranes: studies of cytochrome P450scc topology by limited proteolysis.
    Krivosheev AV; Usanov SA
    Biochemistry (Mosc); 1997 Oct; 62(10):1064-73. PubMed ID: 9461629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langmuir-Blodgett films of cytochrome P450scc and its complex with adrenodoxin.
    Guryev OL; Dubrovsky TB; Chernogolov AA; Dubrovskaya SB; Nicolini C; Usanov SA
    Biochemistry (Mosc); 1997 Jun; 62(6):641-7. PubMed ID: 9284546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of bovine adrenodoxin by protein kinase CK2 affects the interaction with its redox partner cytochrome P450scc (CYP11A1).
    Bureik M; Zöllner A; Schuster N; Montenarh M; Bernhardt R
    Biochemistry; 2005 Mar; 44(10):3821-30. PubMed ID: 15751958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and function of fusion enzymes of the human cytochrome P450scc system.
    Harikrishna JA; Black SM; Szklarz GD; Miller WL
    DNA Cell Biol; 1993 Jun; 12(5):371-9. PubMed ID: 8517924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulation of truncated bovine adrenodoxin.
    Shakya SK; Gu W; Helms V
    Biopolymers; 2005 May; 78(1):9-20. PubMed ID: 15690412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycistronic expression of the mitochondrial steroidogenic P450scc system in the HEK293T cell line.
    Efimova VS; Isaeva LV; Labudina AA; Tashlitsky VN; Rubtsov MA; Novikova LA
    J Cell Biochem; 2019 Mar; 120(3):3124-3136. PubMed ID: 30272820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of catalytic domains in cytochrome P450scc--adrenodoxin reductase--adrenodoxin fusion protein imported into yeast mitochondria.
    Novikova LA; Nazarov PA; Saveliev AS; Drutsa VL; Sergeev VN; Miller WL; Luzikov VN
    Biochemistry (Mosc); 2000 Dec; 65(12):1362-6. PubMed ID: 11173506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and functioning of fused cholesterol side-chain cleavage enzymes.
    Nazarov PA; Drutsa VL; Miller WL; Shkumatov VM; Luzikov VN; Novikova LA
    DNA Cell Biol; 2003 Apr; 22(4):243-52. PubMed ID: 12823901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of cytochrome P450scc. II. Effect of replacement of the Arg425 and Arg426 residues on the structural and functional properties of the cytochrome P450scc.
    Azeva TN; Gilep AA; Lepesheva GI; Strushkevich NV; Usanov SA
    Biochemistry (Mosc); 2001 May; 66(5):564-75. PubMed ID: 11405894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of bovine adrenodoxin with CYP11A1 (cytochrome P450scc) and CYP11B1 (cytochrome P45011beta ). Acceleration of reduction and substrate conversion by site-directed mutagenesis of adrenodoxin.
    Schiffler B; Kiefer M; Wilken A; Hannemann F; Adolph HW; Bernhardt R
    J Biol Chem; 2001 Sep; 276(39):36225-32. PubMed ID: 11459837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of proteins in the cholesterol side-chain cleavage system in JEG-3 and Y-1 cells.
    Black SM; Szklarz GD; Harikrishna JA; Lin D; Wolf CR; Miller WL
    Endocrinology; 1993 Feb; 132(2):539-45. PubMed ID: 8425475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.